Accès ouvert
2026
article
OpenAlex
Britt‐Marie Ekman‐Joelsson, Michal Odermarsky, Karin Tran‐Lundmark, Maria Sjöborg Alpman et autres
Background: Posttransplant lymphoproliferative disorder (PTLD) is a potentially lethal complication after pediatric heart transplantation (PHT). We have previously reported an association between PTLD and (1) sternotomy during infancy, (2) mismatch concerning Epstein-Barr virus infection, (3) hypoplastic left ventricle and (4) surgically palliated …
se
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Cristina Almagro-Pérez, Niccolò Peruzzi, Csaba Galambos, Andrew H. Song et autres
Histologically stained tissue sections are considered the gold standard for studying microscopic anatomy and diagnosing disease in clinical practice. However, the processes of sectioning and staining are laborious, and the overall method relies on two-dimensional analysis. In contrast, X-ray-based virtual histology offers …
ch, se, us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
M Moss, Timothy Klouda, Y Li, Ying Liu et autres
BACKGROUND: Pulmonary arterial hypertension (PAH) is characterized by excessive remodeling of the distal arterioles and arteries, driven by endothelial cell (EC) apoptosis and uncontrolled mural cell proliferation. Increasing evidence suggests immune dysregulation in PAH, but one crucial part of the immune system, …
us, se
(code pays fourni par la source)
2026
article
OpenAlex
Oscar van der Have, Rachel K. Hopper, Rebecca J. Kameny, Karin Tran‐Lundmark
PURPOSE OF REVIEW: This review aims to give an overview of recent advances in the clinical management of children <18 years of age with end-stage pulmonary hypertension refractory to conventional medical therapy. RECENT FINDINGS/SUMMARY: The increased awareness and characterization of pediatric pulmonary …
se, us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Oscar van der Have, Michal Odermarsky, Thomas Möller, Klaus Juul et autres
BACKGROUND: Pediatric heart-lung transplantation (pHLTx) remains the only treatment option for children with significant and fixed elevation of pulmonary vascular resistance (PVR) in the setting of uncorrectable end-stage heart disease. We aimed to determine the characteristics, waiting list course and long-term outcomes …
se, no, dk, fi
(code pays fourni par la source)
Accès ouvert
2026
supplementary-materials
OpenAlex
Cristina Almagro-Pérez, Niccolò Peruzzi, Csaba Galambos, Andrew Song et autres
SI_RoyalSociety_VISTACT_revised_12April2026.pdf
Accès ouvert
2026
supplementary-materials
OpenAlex
Cristina Almagro-Pérez, Niccolò Peruzzi, Csaba Galambos, Andrew Song et autres
SI_RoyalSociety_VISTACT_revised_12April2026.pdf
2026
preprint
OpenAlex
Niccolò Peruzzi, Ayse Ceren Mutgan, Kinga I. Gawlik, Timothy J. Mead et autres
1. Abstract Congenital heart disease is commonly studied using genetically modified mouse models, but characterization of complex three-dimensional (3D) cardiac anomalies remains technically challenging. Histology of fixed paraffin-embedded samples, typically used for structural and molecular analysis, is limited to two dimensions (2D). …
se, us, ch
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Oscar van der Have, Esme Dunne, Karin Tran‐Lundmark, Julie Wacker et autres
We sought to investigate the inter- and intra-country variation in paediatric heart transplantation (HTx) and mechanical circulatory support (MCS) availability and practice in Europe. Data was obtained through a survey circulated to paediatric transplant cardiologists identified through the Association of European Paediatric …
se, ie, ch, us, at, cz, de, be, is, nl, hr, si, lv, tr, it, dk, ba, pt, pl, fi, hu, ro, sk, gb, no, fr
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Mikaela Dolk, Indra Schütz, Erik Herou, Felicia Nordenstam et autres
OBJECTIVE: To characterize patients with protein-losing enteropathy (PLE) diagnosed before age 18 years within a nationwide Swedish Fontan cohort. METHODS: Surgical records and medical charts were reviewed for all patients born after January 1, 1993, who underwent Fontan completion before January 1, …
se
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Katharina Schimmel, Evon DeBose-Scarlett, Yue Qi, Serena Y. Tan et autres
Background: Hereditary hemorrhagic telangiectasia (HHT) and hereditary pulmonary arterial hypertension (HPAH) are genetic diseases that affect the pulmonary vasculature. HHT and HPAH are due to a haploinsufficiency in components of the bone morphogenetic protein receptor type 2 (BMPR2) pathway. Despite shared genetics, …
us, se
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Philip Tannenberg, Karin Tran‐Lundmark, Ya‐Ting Chang, Hanna Gladh et autres
ABSTRACT Pulmonary arterial hypertension (PAH) is a life‐threatening condition with no cure, making research into its underlying mechanisms critical. The platelet‐derived growth factor (PDGF) signaling pathway plays a crucial role in vascular remodeling, a key factor in PAH progression. Anti‐PDGF receptor therapies, …
se, tw
(code pays fourni par la source)